Clinical trial
A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris
NCT00663286 is registered in ClinicalTrials.gov with Dow Pharmaceutical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris
- Lead sponsor
- Dow Pharmaceutical Sciences
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2006
- Completion date
- Not reported
- Enrollment
- 1,399 (actual)
- Sites
- 33
Conditions
As the registry lists them; a condition with its own page is linked.